March 8 (Reuters) - Syndax Pharmaceuticals Inc :
* SYNDAX PHARMACEUTICALS REPORTS FOURTH QUARTER 2020 FINANCIAL RESULTS AND PROVIDES CLINICAL AND BUSINESS UPDATE
* Q4 LOSS PER SHARE $0.44
* Q4 EARNINGS PER SHARE ESTIMATE $-0.49 -- REFINITIV IBES DATA
* END OF YEAR CASH BALANCE OF $293.1 MILLION PROVIDES CASH RUNWAY INTO 2023
Source text for Eikon: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;)
* SYNDAX PHARMACEUTICALS REPORTS FOURTH QUARTER 2020 FINANCIAL RESULTS AND PROVIDES CLINICAL AND BUSINESS UPDATE
* Q4 LOSS PER SHARE $0.44
* Q4 EARNINGS PER SHARE ESTIMATE $-0.49 -- REFINITIV IBES DATA
* END OF YEAR CASH BALANCE OF $293.1 MILLION PROVIDES CASH RUNWAY INTO 2023
Source text for Eikon: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;)